- Coordinator
- Universite De Montpellier, France
- Runs
- 1 October 2022 to 30 September 2026
- Status
- Running
- EU funding
- €7.4m
- Total cost
- €7.7m
- Partners
- 20 organisations in 12 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101057286
What the project is doing
In the project's own words, from its summary on CORDIS.
The environmental impact of the pharmaceutical industry is a huge problem. The production and use of pharmaceuticals cause high CO2 emissions, contamination of soils, biota, and water, and even dangers to human health through carcinogenic impurities. Especially the use of solvents is a major problem. The European Green Deal has led to strict regulations on environmental pollution by the pharma industry, causing manufacturers to move outside of the EU due to the high costs associated with green pharma.
This results in supply chain fragility and low crisis preparedness in Europe. New methods to produce pharmaceuticals in a green, efficient, and economically friendly way are required. The IMPACTIVE project brings together the expertise and knowledge from two COST Actions and will develop novel green methods to produce active pharmaceutical ingredients (APIs) using mechanochemistry as a disruptive technology (as acknowledged by IUPAC).
Mechanochemistry uses mechanical processes, such as ball milling, twin-screw extrusion, resonant acoustic mixing, and spray drying, to induce chemical reactions. The advantages of mechanochemistry include: no solvent use, high efficiency, low costs, and reduced energy use and CO2 emission. Upon completion of the project, we will provide proof-of-concept at a small pilot scale of the use of mechanochemistry to produce 6 APIs from 3 different families of compounds.
Based on a recent study, switching to mechanochemistry can reduce terrestrial ecotoxicity and CO2 emissions by more than 85%, while production costs were reduced with 12%. The results of the IMPACTIVE project will thus enable pharmaceutical manufacturers to move back to Europe while minimizing environmental pollution. Through our strong dissemination and communication strategy we will ensure that the project?s results are shared with scientists, the pharmaceutical industry, and stakeholders from regulatory and public authorities to achieve maximum impact.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universite De Montpellier | Montpellier | France | Coordinator |
| Universite Catholique De Louvain | Louvain La Neuve | Belgium | Participant |
| Haute Ecole Specialisee De Suisse Occidentale | Delemont | Switzerland | Associatedpartner |
| Novartis Pharma AG | Basel | Switzerland | Associatedpartner |
| Sigma-Aldrich Production GmbH | Buchs | Switzerland | Associatedpartner |
| Bundesanstalt Fuer Materialforschung Und -Pruefung | Berlin | Germany | Participant |
| Max Planck Institut Fuer Kohlenforschung | Muelheim An Der Ruhr | Germany | Participant |
| Rheinisch-Westfaelische Technische Hochschule Aachen | Aachen | Germany | Participant |
| Tallinna Tehnikaülikool | Tallinn | Estonia | Participant |
| Agata Comunicacion Cientifica SL | Santander | Spain | Participant |
| Axlr Satt Occitanie Mediterranee | Montpellier | France | Participant |
| Ecole Nationale Superieure De Chimie De Montpellier | Montpellier Cedex 5 | France | Third party |
| The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin | Dublin | Ireland | Participant |
| Technion - Israel Institute of Technology | Haifa | Israel | Participant |
| Consorzio Interuniversitario Perlo Sviluppo Dei Sistemi a Grande Interfase | Firenze | Italy | Participant |
| Universita Degli Studi Di Cagliari | Cagliari | Italy | Third party |
| Stichting Radboud Universiteit | Nijmegen | Netherlands | Participant |
| Des Solutio - Solucoes E Consultoria Cientifica Lda | Charneca De Caparica | Portugal | Participant |
| Ist-Id Associacao Do Instituto Superior Tecnico Para a Investigacao E O Desenvolvimento | Lisboa | Portugal | Participant |
| Johnson Matthey plc | Royston | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI